Back to 
SUSQUEHANNA INTERNATIONAL GROUP, LLP
SUSQUEHANNA INTERNATIONAL GROUP, LLP
CLDXShowing 8 of 31 quarters
Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in Celldex Therapeutics, Inc.
SUSQUEHANNA INTERNATIONAL GROUP, LLP holds 19,080 shares of CLDX (Celldex Therapeutics, Inc.), worth $709,967 as of 2026-Q2. The position was decreased (-46.9% shares). CLDX represents 0.0% of SUSQUEHANNA INTERNATIONAL GROUP, LLP's portfolio.
Current Value
$709,967
Current Shares
19,080
Total Value Change
-$1.5M
Total Shares Change
-45,496
Quarter-by-Quarter History
Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP